Svenska Cellulosa AB SCA Class A · OMXSTO:SCA_A

Svenska Cellulosa AB SCA Class A — SCA — Handelsbanken conference 2012

18 slides from Svenska Cellulosa AB SCA Class A's conference presentation, September 2012

  1. Slide 1: Handelsbanken conference

    Handelsbanken conference Jan Johansson, President and CEO

  2. Slide 2: Major changes

    Major changes  Divestment of the Packaging business, excluding the two kraftliner mills  Acquisition of Georgia-Pacific’s European tissue operations  Established joint venture in Australia/New Zealand  Acquisition of Everbeauty an Asian hygiene products company  Increased shareholding in Vinda

  3. Slide 3: Acquisition of Georgia-Pacific's European tissue operations

    Acquisition of Georgia-Pacific’s European tissue operations  Creates a leading European tissue company  Strengthens SCA’s product offering and geographic presence  Sales: EUR 1.25bn  Purchase price: EUR 1.32bn  Annual synergies: EUR 125m  With full implementation of synergies, earnings per sha

  4. Slide 4: SCA Group

    SCA Group  Net sales of SEK 91bn*  37,000 employees and sales in more than 100 countries  World’s second-largest hygiene company  TEN and Tork are leading global brands for incontinence care and AFH tissue  Europe’s largest private forest owner  Europe’s second-largest sawmill company * 2011 s

  5. Slide 5: SCA Group: Hygiene business is growing

    SCA Group Hygiene business is growing % of net sales ~20%* 54% 40% 46% 60% ~80%* Forest Products and Hygiene products Packaging (Personal Care and Tissue) 5 September 2012

  6. Slide 6: Leading market positions

    Leading market positions Globally and regionally Nordic region North America Incontinence products: 1 Europe AFH tissue: 3 Baby diapers: 1 Tissue: 1 Incontinence products: 3 AFH tissue: 1 Solid-wood products: 2 Consumer tissue: 2 Baby diapers: 3 Mexico Incontinence products: 1 Incontinence products:

  7. Slide 7: SCA Group's strategic priorities

    SCA Group’s strategic priorities EFFICIENCY INNOVATION GROWTH 7 September 2012

  8. Slide 8: Efficiency

    Efficiency  Restructuring programme in baby diapers in Europe completed  Efficiency programme  Mainly related to Personal Care and Tissue  Annual cost saving: SEK 700m  Gradual impact in 2012-2013  Investments in upgrade of existing and new capacity 8 September 2012

  9. Slide 9: Innovation

    Innovation Strengthens market positions and profitability 9 September 2012

  10. Slide 10: September 2012

    10 September 2012

  11. Slide 11: Growth

    Growth  Sales growth of 4%*  High growth in emerging markets  Acquisition of Georgia-Pacific´s European tissue operations  Acquisition in Brazil  Pro Descart, No. 2 in incontinence care  Acquisition in Turkey  San Saglik 95%, No. 2 in incontinence care  Komili 50%, No. 4 in baby diapers and

  12. Slide 12: Growth potential for hygiene products

    Growth Growth potential for hygiene products  Global population growth  An aging population  Increased market penetration  Higher disposable income  Customers and consumers demand more comfort and sustainability 12 September 2012

  13. Slide 13: High potential in markets with low penetration

    Growth High potential in markets with low penetration Usage of hygiene products Units/capita/year Units/child/year Units/woman/year Kg/capita/year North America Western Europe Eastern Europe Latin America Asia 13 September 2012

  14. Slide 14: Macro update

    Macro update Q2 2012  Global economy and private consumption to slow in 2012  Debt crisis in parts of Western Europe has a negative impact  Emerging markets shows relatively good growth  Hygiene products  Good growth in Emerging markets  Low or no growth in Western Europe and North America  F

  15. Slide 15: Q2 2012 results

    Q2 2012 results SEK millions Q2 Q2 Change, Change, unless otherwise stated 2012 2011 % %** Net sales 20,273 20,415 -1 2 EBIT* 2,105 1,810 16 16 EBIT margin* (%) 10.4 8.9 Profit before tax* 1,789 1,527 17 Earnings per share (SEK) 1.85 1.96 Operating cash flow 2,391 1,868 Debt/Equity ratio 0.41 0.55 *

  16. Slide 16: Key reasons to invest in SCA

    Key reasons to invest in SCA  Transformation story  Strong product portfolio  Good growth opportunities  Profitability improvement potential  Good dividend yield 16 September 2012

  17. Slide 17: Q&A

    Q&A 17 September 2012

  18. Slide 18: IR Contacts

    IR Contacts: Johan Karlsson, VP Investor Relations Tel: +46 8 788 51 30 Email: ir@sca.com Website: www.sca.com

SCA — Handelsbanken conference 2012 on 6ix